November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

Conexiant

November 20, 2024

Topical Ruxolitinib Offers Rapid Relief for Atopic Dermatitis

Conexiant

November 19, 2024

Art-Based Training Improves Neurology Observational Skills

Conexiant

November 18, 2024

Renowned Dermatologist Goldsmith Dies at 86

"No one ever trades in a Rolls Royce—they just maintain the one they have," quipped pioneering dermatologist Lowell Goldsmith after cardiac surgery, exemplifying the wit and wisdom that marked his 57-year career advancing dermatologic medicine.

Conexiant

November 15, 2024

Global Study Finds Pruritus Affects 40% of Adults Worldwide

Patients with skin conditions are three times more likely to experience pruritus, highlighting a critical link between dermatologic health and quality of life.

Conexiant

November 04, 2024

Upadacitinib Study Shows Sustained Atopic Dermatitis Results

New data from three Phase 3 trials show upadacitinib maintains strong efficacy and safety in adolescent atopic dermatitis, with significant improvements in pruritus and skin clearance.

Conexiant

October 31, 2024

FDA Grants New EB Treatment Designation

Squamous cell carcinoma is the leading cause of mortality in severe epidermolysis bullosa," notes Dr. Robert Kirsner, as FDA grants rare pediatric designation to mitochondrial-targeting therapy.

Conexiant

October 29, 2024

Study: Parent Physicians Face $2M Pay Gap

Parent physicians face stark earning divides: mothers' pay drops with each child while fathers see raises, creating $2M career gap.

Conexiant

October 29, 2024

Proactive Drug Monitoring in IBD & Arthritis

A recent study suggests that proactive monitoring of infliximab during maintenance therapy may increase sustained disease control in patients with inflammatory bowel disease and arthritis, potentially adding 146 more patients per 1,000 to annual remission rates.

Conexiant